Discovery of TAK-981, a First-in-Class Inhibitor of SUMO-Activating Enzyme for the Treatment of CancerSteven Langston, Xiaofeng Yang, Scott Freeze et al.|Journal of Medicinal Chemistry|2021Cited by 205
Reaction hijacking of tyrosine tRNA synthetase as a new whole-of-life-cycle antimalarial strategyStanley C. Xie, Leann Tilley, Carlo Giannangelo et al.|Science|2022Cited by 56
Design and Optimization of Potent and Orally Bioavailable Tetrahydronaphthalene Raf InhibitorsAlexandra E. Gould, Katherine Galvin, Misook Kim et al.|Journal of Medicinal Chemistry|2011Cited by 33
Discovery and optimization of pyrazoline compounds as B-Raf inhibitorsMatthew O. Duffey, Qin Zhang, Johnny Yang et al.|Bioorganic & Medicinal Chemistry Letters|2010Cited by 15
Optimization of tetrahydronaphthalene inhibitors of Raf with selectivity over hERGShih‐Chung Huang, Alexandra E. Gould, M. D. Smith et al.|Bioorganic & Medicinal Chemistry Letters|2016Cited by 10